BU-NOT-SET

CONTACT US
Stability studies are ever changing: Outsourcing as a viable option
  • Analytical chemistry
Development workers
Insight
Navigating the regulatory landscape for controlled substances
  • Drug substance
Man at work
Insight
How to speed up vaccine development and production
  • Manufacturing
Vaccine
eBook
Reducing time to market with analytical chemistry
  • Analytical chemistry
Workers
Insight
Serialisation – Looking for value-added opportunities
  • Manufacturing
Eyes
Insight
Outlining the key steps to analytical method development
  • Analytical chemistry
Eyes
Insight
Outsourcing formulation development & manufacturing
  • Drug product
Eyes
Insight
Complying with Annex 1: Things to bear in mind
  • Drug product
Eyes
Insight
Optimising a prolonged release fixed dose combination product
  • Drug product
pills
Case study
Insight
  • Drug product
  • Industry trends
Three challenges pharma companies can overcome when choosing the right OSD partner
Insight
  • Sustainability
Sustainable pharmaceutical supply chains with the Science Based Targets initiative
Insight
How CDMO partnerships can accelerate vaccine development
Insight
  • Analytical chemistry
  • Drug product
Optimising extractables and leachables testing
Fact sheet
  • Drug product
  • Manufacturing
Ready-to-use (RTU) pre-filled syringes and cartridges system
Insight
  • Drug product
  • Manufacturing
Recipharm’s latest investment will help meet blow-fill-seal (BFS) demand
Insight
  • Drug product
  • Industry trends
Which biologics trends in the OSD space are set to impact drug development in 2023?
Insight
  • Drug product
  • Industry trends
What are the key learnings from 2022 in pharma?
Insight
  • Drug product
  • Manufacturing
Overcoming the pitfalls of pre-filled syringe filling